Charles Large

Charles Large is the Chief Executive Officer at Autifony Therapeutics Limited.
Specialties: Neuroscience, Electrophysiology, Psychiatric disorders, Epilepsy, Transcranial Magnetic Stimulation, Ion Channels, Lamotrigine, Drug Discovery.

Autifony Therapeutics aims to develop new drugs to treat serious disorders of the central nervous system using pioneering science.
Country: UK
Visit Website